Measurement and importance of plasma brain natriuretic peptide and related peptides

Annals of Clinical Biochemistry

Volumn 38, Issue 2, 2001, Pages 83-93

  Sagnella, G A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ACCURACY; AMINO ACID SEQUENCE; ANALYTIC METHOD; CONGESTIVE HEART FAILURE; HUMAN; IMMUNORADIOMETRIC ASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD SPECIMEN COLLECTION; FORECASTING; HUMANS; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; MOLECULAR SEQUENCE DATA; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; RADIOIMMUNOASSAY;

EID: 0035104757     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563011900317     Document Type: Review

References (58)

1. Evidence of the atrial location of receptors influencing urine flow
2. Specific granules in atrial muscle cells
3. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
4. Atrial natriuretic factor: A hormone produced by the heart
5. Atrial natriuretic factor: Structure and functional properties
6. Atrial natriuretic peptides
7. Human plasma atrial natriuretic peptide concentration in health and disease
8. Molecular biology and biochemistry of the natriuretic peptide system I: Natriuretic peptides
9. C-type natriuretic peptide
10. A new natriuretic peptide in porcine brain
11. Isolation and sequence determination of human brain natriuretic peptide in human atrium
12. Renal, endocrine, and haemodynamic effects of human brain natriuretic peptide in normal man
13. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure
14. Measurement and significance of circulating natriuretic peptides in cardiovascular disease
15. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
16. Natriuretic peptides in assessment of left-ventricular dysfunction
17. Elevated plasma C-type natriuretic peptide concentrations in patients with chronic renal failure
18. The scale of heart failure: Diagnosis and management of issues for primary care
19. Brain natriuretic peptide-like immunoreactivity is present in human plasma
20. Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid
21. Brain natriuretic peptide as a cardiac hormone in essential hypertension
22. Dietary sodium loading increases plasma brain natriuretic peptide levels in man
23. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
24. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-dependent or dialysis independent chronic renal failure
25. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy
26. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
27. Assay of brain natriuretic peptide (BNP) in human plasma: Evidence for high molecular weight BNP as a major plasma component in heart failure
28. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy
29. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases
30. Biochemical detection of left-ventricular systolic dysfunction
31. The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32
32. Circulating forms of B-type natriuretic peptide after acute myocardial infarction
33. An immunoradiometric assay for brain natriuretic peptide in human plasma
34. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
35. Atrial and brain natriuretic peptides in cardiovascular diseases
36. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
37. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
38. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis
39. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodelling after acute myocardial infarction
40. Analytical agreement and clinical correlates of plasma brain natriuretic peptide measured by three immunoassays in patients with heart failure
41. Stabilization of human brain natriuretic peptide in blood samples
42. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: Implications for clinical practice
43. Prolonged stability of brain natriuretic peptide: Importance for non-invasive assessment of cardiac function in clinical practice
44. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension
45. Brain natriuretic peptide in an elderly population
46. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?
47. Brain and atrial natriuretic peptides: A dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension
48. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment
49. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
50. An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: Development of a test for left ventricular dysfunction
51. Enzymimmunoassays für proBNP fragmente (8-29) und (32-57)
52. Development of a novel N-terminal proBNP(NT-proBNP) assay with a low detection limit
53. Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry
54. Medicare, Medicaid and CLIA programs; Regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Final rule
55. Validating aminoterminal BNP assays: A word of caution
56. Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage. Clinical and TCD correlations
57. Present issues in the determination of troponins and other markers of cardiac damage
58. Towards a blood test for heart failure: The potential use of circulating natriuretic peptides